While randomizing patients into a clinical trial is a key part of advancing medical breakthroughs, reaching adequate patient enrollment numbers still poses a challenge for sponsors, sites, and research staff. It is not uncommon for trials to close due to a lack of enrollment, which results in significant costs, wasted resources, and stifled research advancement.
Continue reading